Nora Inion de Iannino, Gabriel Briones, Gabriel Kreiman, Rodolfo Ugalde

Characterization of the Biosynthesis of betha(1-2) Cyclic Glucan in R. Fredii. betha(1-2) Glucan has no Apparent Role in Nodule Invasion of McCall and Peking Soybean Cultivars

Cellular and Molecular Biology (1996) 42:617-629 PDF


Three wild type strains of Rhizobium fredii, USDA 191, USDA 257 and HH 303, do not synthesize in vivo or in vitro b (1-3), b (1-6) cyclic glucans, all strains form in vitro and in vivo cyclic beta(1-2) glucans. Approximately 80% of the recovered R. fredii cellular cyclic b (1-2) glucans were anionic and the substituent was identified as phosphoglycerol. Inner membranes prepared from these R.fredii strains have a b (1-2) glucan-intermediate-protein with apparent molecular mass undistinguishable from Agrobacterium tumefaciens b (1-2) glucan intermediate protein. Studies of the degree of polymerization of the oligosaccharides recovered from the protein-intermediate after short pulse incubations with UDP-C-14-glucose suggested that the rate limiting step in the biosynthesis of cyclic glucan is cyclization. Kinetic studies revealed that the K-m for UDP-glucose was 0.33 mM. No difference was detected between the K-m for initiation/elongation and cyclization reactions. Nodulation studies of a ndvB R. fredii mutant with Me Call and Peking soybean cultivars, revealed that b (1-2) glucans do not seem to be required for normal nodule invasion of these soybean cultivars.

KREIMAN LAB


Department of Ophthalmology
Program in Neurobiology
Children's Hospital Harvard Medical School
Center for Brain Science, Harvard University
Swartz Center for Theoretical Neuroscience    

 

 

HOME . PUBLICATIONS . COURSES

PEOPLE . ACKNOWLEDGMENTS

OUTREACH . CONTACT